Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Jasper Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 25 | 1 | 24 | 0 |
| Shares | 20.9M | 218.1K | 20.1M | −612.5K (−3.0%) |
| Value | $160.7M | $1.71M | $69.6M | −$89.3M (−56.2%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Jasper Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sectoral Asset Management Inc | 675,000 | $2.40M | 0.43% |
| Forefront Analytics, LLC | 32,550 | $118.0K | 0.04% |
| BIT Capital GmbH | 30,000 | $106.5K | 0.01% |
| State Street Corp | 21,752 | $77.0K | 0.00% |
| Renaissance Technologies LLC | 10,871 | $39.0K | 0.00% |
| Highbridge Capital Management LLC | 741 | $3.00K | 0.00% |
Sold out (6)
Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Virtu Financial LLC | 20,743 | $163.0K |
| Millennium Management LLC | 19,922 | $156.0K |
| Truist Financial Corp | 11,250 | $89.0K |
| Paloma Partners Management Co | 10,141 | $80.0K |
| UBS Group AG | 2,552 | $20.0K |
| Simplex Trading, LLC | 700 | $5.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Grace Capital | 218,110 | $1.71M |